Avisco

Company Overview

Snapshot

Founded in February 2002 by Ur Finkelstein, Avisco operates with 1–10 employees. The company holds patents for its technology and products, including AIVOREX, a standardized Inula viscosa oleo resin extract. Avisco was recognized as the first place winner of the global GC3 Challenge for Novel Green Preservatives.

Business overview

Avisco is a biotechnology company focused on cultivating Inula viscosa to produce standardized herbal therapeutic and skincare formulations. The company's core technology involves the cultivation, processing, extraction, production, standardization, and quality control of Inula viscosa. Avisco serves markets in the United States, United Kingdom, Netherlands, Israel, and India, operating within the agriculture and food technologies sector, with applications spanning pharmaceuticals, cosmetics, and marine industries.

Company Intelligence Q&A

What is Avisco's primary focus?

Avisco specializes in biotechnology, focusing on introducing Inula viscosa from the wild for cultivation as a standardized crop to develop herbal therapeutic and skincare formulations.

Who founded Avisco and when?

Avisco was founded in February 2002 by Ur Finkelstein.

What proprietary products does Avisco offer?

Avisco offers proprietary products such as AIVOREX, a standardized Inula viscosa oleo resin extract, and has developed a non-toxic preservative for skincare and deodorants, as well as an Inula viscosa extract-based marine anti-fouling coating.

Has Avisco received any notable recognition?

Avisco was the first place winner of the global GC3 Challenge for Novel Green Preservatives.

What intellectual property does Avisco hold?

Avisco holds patents for its technology and products, including AIVOREX, and possesses intellectual property rights to unpublished studies and Inula viscosa extract applications.